Бренда Дэвис - Как победить диабет. Руководство по питанию и образу жизни

26. Agrawal NK. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes . 2014; 5(5): 697.

27. Odegaard AO, Jacobs DR, Sanchez OA, et al. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol . 2016; 15(1): 1–12.

28. Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules . 2015; 5(1): 194–222.

29. Morales PE, Bucarey JL, Espinosa A. Muscle lipid metabolism: Role of lipid droplets and perilipins. J Diabetes Res . 2017; 2017: 1789395.

30. Li Y, Xu S, Zhang X, Yi Z, Cichello S. Skeletal intramyocellular lipid metabolism and insulin resistance. Biophys Reports . 2015; 1(2): 90–98.

31. Yazıcı D, Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol . 2017; 960: 277–304.

32. Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism . 2016; 65(8): 1049–1061.

33. Roseman HM. Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. J Manag Care Pharm . 2005; 11(6 Suppl B): S3–11.

34. Del Turco S, Gaggini M, Daniele G, et al. Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. Curr Pharm Des . 2013; 19(13): 2420–2431.

35. Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R. Metabolic endotoxemia: A molecular link between obesity and cardiovascular risk. J Mol Endocrinol . 2013; 51(2).

36. Caricilli A, Saad M. The Role of Gut Microbiota on Insulin Resistance. Nutrients . 2013; 5(3): 829–851.

37. Scheithauer TPM, Dallinga-Thie GM, de Vos WM, et al. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Mol Metab . 2016; 5(9): 759–770.

38. Martínez Steele E, Popkin BM, Swinburn B, Monteiro CA. The share of ultra-processed foods and the overall nutritional quality of diets in the US: evidence from a nationally representative cross-sectional study. Popul Health Metr . 2017; 15(1):6.

39. Gibney MJ, Forde CG, Mullally D, Gibney ER. Ultra-processed foods in human health: a critical appraisal. Am J Clin Nutr . 2017; 106(3): ajcn160440.

40. Blumenthal DM, Gold MS. Neurobiology of food addiction. Curr Opin Clin Nutr Metab Care . 2010; 13(4): 359–365.

41. Daily Mail Reporter. How the size of an average restaurant meal has QUADRUPLED since the 1950s – with U.S. burgers now three times as big | Daily Mail Online. Daily Mail. URL: http://www.dailymail.co.uk/news/article-2148970/How-size-average-restaurant-meal-QUADRUPLED-1950s-U-S-burgers-times-big.html. Published 2012. Accessed July 14, 2018.

42. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev . 2008; 32(1): 20–39.

43. U.S. Dept of Health and Human Services. CDC. H ealth, United States, 2016. W.S. Government Printing Office. Washington DC. 2017. URL: https://www.cdc.gov/nchs/data/hus/hus16.pdf#053. Accessed July 14, 2018.

Глава 2

1. Brown A, Guess N, Dornhorst A, Taheri S, Frost G. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done? Diabetes, Obes Metab . 2017; 19(12): 1655–1668.

2. Waugh N, Cummins E, Royle P, et al. Newer agents for blood glucose control in type 2 diabetes: Systematic review and economic evaluation. Health Technol Assess (Rockv) . 2010; 14(36): 3–247.

3. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care . 2009; 32(11): 2133–2135.

4. Cummings DE, Rubino F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia . 2018; 61(2): 257–264.

5. Steven S, Carey PE, Small PK, Taylor R. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabet Med . 2015; 32(1): 47–53.

6. Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: Normalization of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia . 2011; 54(10): 2506–2514.

7. Bhatt AA, Choudhari PK, Mahajan RR, et al. Effect of a Low-Calorie Diet on Restoration of Normoglycemia in Obese subjects with Type 2 diabetes. Indian J Endocrinol Metab . 2017; 21(5): 776–780.

8. Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet (London, England) . 2018; 391(10120): 541–551.

9. Dunaief DM, Fuhrman J, Dunaief JL, Ying G. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open J Prev Med . 2012; 2(3): 364–371.

10. Eddy JV. E4 Alive Diabetes Solutions. URL: http://www.e4balance.org/ds/. Accessed August 18, 2018.

11. Kiehm TG, Anderson JW, Ward K. Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am J Clin Nutr . 1976; 29(8): 895–899.

12. Anderson JW. Effect of carbohydrate restriction and high carbohydrate diets on men with chemical diabetes. Am J Clin Nutr . 1977; 30(3): 402–408.

13. Anderson JW, Ward K. Long-term effects of high-carbohydrate, high-fiber diets on glucose and lipid metabolism: a preliminary report on patients with diabetes. Diabetes Care . 1978; 1(2): 77–82.

14. Anderson JW. High carbohydrate, high fiber diets for patients with diabetes. Adv Exp Med Biol . 1979; 119: 263–273.

15. Anderson JW. High-fibre diets for diabetic and hypertriglyceridemic patients. Can Med Assoc J . 1980; 123(10): 975–979.

16. Story L, Anderson JW, Chen WJ, Karounos D, Jefferson B. Adherence to high-carbohydrate, high fiber diets: long-term studies of non-obese diabetic men. J Am Diet Assoc . 1985; 85(9):1105–1110.

17. Anderson JW, Zeigler JA, Deakins DA, et al. Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr . 1991; 54(5): 936–943.

18. Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low calorie diet program for severe obesity. Am J Gastroenterol . 1992; 87(1):6–15.

19. Anderson JW, Brinkman-Kaplan V, Hamilton CC, et al. Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM. Diabetes Care . 1994; 17(6): 602–604.

20. Collins RW, Anderson JW. Medication cost savings associated with weight-loss for obese noninsulin-dependent diabetic men and women. Prev Med (Baltim) . 1995; 24(4): 369–374.

21. Geil PB, Anderson JW. Nutrition and health implications of dry beans: a review. J Am Coll Nutr . 1994; 13(6): 549–558.

22. Anderson JW, Major AW. Pulses and lipaemia, short- and long-term effect: Potential in the prevention of cardiovascular disease. Br J Nutr . 2002; 88(S3): 263.

23. Anderson JW, Allgood LD, Turner J, et al. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr . 1999; 70(4): 466–473.

24. Anderson JW. Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc . 2003; 62(01): 135–142.

25. Anderson JW, Waters AR. Raisin Consumption by Humans: Effects on Glycemia and Insulinemia and Cardiovascular Risk Factors. J Food Sci . 2013; 78(s1): A11–A17.